Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

NicOx grants Bausch & Lomb worldwide rights to NCX-116

March 4, 2010

Seattle Genetics achieves milestone under antibody-drug conjugate collaboration with Genentech

March 4, 2010

Bristol-Myers Squibb and Allergan enter global agreement on ExonHit's AGN-209323

March 4, 2010

Nabi stockholders approve NicVAX option and license agreement

March 4, 2010

Abbott and Enanta advance their hepatitis C collaboration

March 3, 2010

Lundbeck inlicenses marketing rights to Azilect in Asian countries

March 3, 2010

Renovo and Shire revise licensing deal for Juvista

March 3, 2010

Shionogi and QuatRx to market and develop ospemifene

March 3, 2010

Watson Pharmaceuticals licenses Population Council's novel contraceptive ring

March 2, 2010

Regulus Therapeutics and GSK establish new microRNA therapeutics collaboration

Feb. 26, 2010

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 13, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...